4. Clinical characteristics of anti-n-methyl-d-aspartate receptor encephalitis of children at National Children’s Hospital
Main Article Content
Abstract
Anti-N-methy-D-aspartate receptor encephalitis is one of the most common autoimmune encephalitis. This study described the clinical characteristics of 41 cases treated at the National Children's Hospital between January 2021 and May 2022. The majority (61%) of patients had unknown etiology; 7.3% were paraneoplastic; and 31.7% had post-infectious anti-NMDA receptor encephalitis. The median age was 4.9 (range: 0.6 - 14.5), and the male/female ratio was 0.95. The most common clinical manifestations were psychosis (63.4%), seizure (61%), fever (53.7%), and sleep disturbances (51.2%). EEG abnormalities were found in 72% of the patients, cerebrospinal fluid changes in 70.7% of patients with slight increase in cell count: 12 (0 - 410), normal protein: 0.31 ± 0.14, lesions on cranial magnetic resonance in 48.6%. Most (82.8%) of patients received first-line immunotherapy, 7.3% received second-line therapy, and 9.8% of patients maintained immunotherapy after second-line therapy. On average, after treatment, the modified Rankin score was reduced by 0.76 points. The median duration of hospitalization was 22 (range: 5-79) days.
Article Details
Keywords
Autoimmune encephalitis, NMDA, children
References
2. Dubey D, Pittock SJ, Kelly CR, et al. Autoimmune Encephalitis Epidemiology and a comparison to Infectious Encephalitis. Published online 2019:21.
3. Granerod J, Ambrose HE, Davies NW, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. The Lancet Infectious Diseases. 2010; 10(12): 835-844. doi:10.1016/S1473-3099(10)70222-X.
4. Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013; 12(2): 157-165. doi:10.1016/S1474-4422(12)70310-1.
5. Dale RC, Nosadini M. Infection-triggered autoimmunity: The case of herpes simplex virus type 1 and anti-NMDAR antibodies. Neurol Neuroimmunol Neuroinflamm. 2018; 5(4): e471. doi:10.1212/NXI.0000000000000471.
6. Pillai SC, Hacohen Y, Tantsis E, et al. Infectious and Autoantibody-Associated Encephalitis: Clinical Features and Long-term Outcome. 2015; 135(4): 13.
7. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011; 10(1): 63-74. doi:10.1016/S1474-4422(10)70253-2.
8. Trần Thị Thu Hương, Phạm Nhật An. Căn nguyên viêm não cấp ở trẻ em tại Bệnh viện Nhi Trung ương. Tạp chí phòng chống bệnh sốt rét và các bệnh ký sinh trùng. 2018; 106(4): 93-96.
9. Cellucci T, Mater HV, Graus F, et al. Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient. Neurology - Neuroimmunology Neuroinflammation. 2020; 7(2). doi:10.1212/NXI.0000000000000663.
10. Hansen KB, Yi F, Perszyk RE, et al. Structure, function, and allosteric modulation of NMDA receptors. Journal of General Physiology. 2018; 150(8): 1081-1105. doi:10.1085/jgp.201812032.
11. Dalmau J, Tüzün E, Wu H yan, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007; 61(1): 25-36. doi:10.1002/ana.21050.
12. Nosadini M, Mohammad SS, Corazza F, et al. Herpes simplex virus-induced anti-N-methyl-d-aspartate receptor encephalitis: a systematic literature review with analysis of 43 cases. Developmental Medicine & Child Neurology. 2017; 59(8): 796-805. doi:10.1111/dmcn.13448.
13. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008; 7(12): 1091-1098. doi:10.1016/S1474-4422(08)70224-2.
14. Barry H, Byrne S, Barrett E, Murphy KC, Cotter DR. Anti-N-methyl-d-aspartate receptor encephalitis: review of clinical presentation, diagnosis and treatment. BJPsych Bull. 2015; 39(1): 19-23. doi:10.1192/pb.bp.113.045518.
15. Nosadini M, Thomas T, Eyre M, et al. International Consensus Recommendations for the Treatment of Pediatric NMDAR Antibody Encephalitis. Neurol Neuroimmunol Neuroinflamm. 2021; 8(5): e1052. doi:10.1212/NXI.0000000000001052.